|
× |
 |
Reboxetine, a Selective Norepinephrine Reuptake Inhibitor, Is an Effective and Well-Tolerated Treatment for Panic Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Sleep Duration, but Not Insomnia, Predicts the 2-Year Course of Depressive and Anxiety Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional PDF |
$40.00 |
|
$40.00 |
|
× |
|
Symptoms of Sexual Dysfunction in Patients Treated for Major Depressive Disorder: A Meta-Analysis Comparing Selegiline Transdermal System and Placebo Using a Patient-Rated Scale PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Care Management Intervention for Noncardiac Chest Pain: Treatment Development and Feasibility Assessment PDF |
$40.00 |
|
$40.00 |
|
× |
|
Zonisamide in the Treatment of Binge Eating Disorder With Obesity: A Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Impact of Depressive Symptoms Compared With Manic Symptoms in Bipolar Disorder: Results of a U.S. Community-Based Sample PDF |
$40.00 |
|
$40.00 |
|
× |
|
An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Relationship Between Smoking and Suicidal Behavior, Comorbidity, and Course of Illness in Bipolar Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? An Analysis of Eligibility Criteria in Randomized Controlled Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
Olanzapine in the Treatment of Pathological Gambling: A Negative Randomized Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
|
